240 W. Willett, “The case for banning trans fats. The FDA’s new policy on these deadly artificial fatty acids is long overdue.”
241 M. de Lorgeril et al., “Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease.”
242 S. C. Johnson et al., “mTOR is a key modulator of ageing and age-related disease.”
243 A. Bruning, “Inhibition of mTOR signaling by quercetin in cancer treatment and prevention.”
244 A. Reinke et al., “Caffeine targets TOR complex I and provides evidence for a regulatory link between the FRB and kinase domains of Tor1p.”
245 G. S. Van Aller et al., “Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor.”
246 Y. Kokubo et al., “The impact of green tea and coffee consumption on the reduced risk of stroke incidence in Japanese population: the Japan public health center-based study cohort.”
247 C. Laurent et al., “Beneficial effects of caffeine in a transgenic model of Alzheimer’s disease-like tau pathology.”
248 F. Yang et al., “Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.”
249 K. Ono et al., “Curcumin has potent anti-amyloidogenic effects for Alzheimer’s beta-amyloid fibrils in vitro.”